Meningiomas and Cognitive Impairment after Treatment: A Systematic and Narrative Review.
attention
cognition
executive function
language
memory
meningioma
neuropsychology
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Apr 2021
13 Apr 2021
Historique:
received:
25
02
2021
revised:
04
04
2021
accepted:
07
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
Clinical outcomes after surgery for intracranial meningiomas might be overvalued as cognitive dimensions and quality of life are probably underreported. This review aims to summarize the current state of cognitive screening and treatment-related outcomes after meningioma surgery. We present a systematic review (Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA-P) 2015-based) of cognitive outcomes after intracranial meningioma surgery. A total of 1572 patients (range 9-261) with a mean age of 58.4 years (range 23-87), and predominantly female (
Identifiants
pubmed: 33924372
pii: cancers13081846
doi: 10.3390/cancers13081846
pmc: PMC8070481
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Radiother Oncol. 2003 Nov;69(2):177-82
pubmed: 14643955
J Neurosurg. 2003 Jan;98(1):21-31
pubmed: 12546348
BMC Med Res Methodol. 2005 Apr 20;5:13
pubmed: 15840177
J Neurooncol. 2012 Oct;110(1):137-44
pubmed: 22837023
Acta Neurol Scand. 2013 Mar;127(3):161-9
pubmed: 22725678
Surg Neurol. 2008 Jan;69(1):51-61; discussion 61
pubmed: 18054616
J Neurosurg. 2016 Jun;124(6):1568-77
pubmed: 26613174
Neurosurgery. 2011 Jul;69(1):72-8; discussion 78-9
pubmed: 21346660
Adv Tech Stand Neurosurg. 2008;33:3-33
pubmed: 18383811
J Neurooncol. 2007 Sep;84(3):271-8
pubmed: 17431545
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
J Neurooncol. 2018 Dec;140(3):605-613
pubmed: 30219943
Brain Imaging Behav. 2020 Dec;14(6):2351-2366
pubmed: 31456158
Neuro Oncol. 2015 Aug;17(8):1121-31
pubmed: 25921022
Neuro Oncol. 2017 Jul 1;19(7):897-907
pubmed: 28039363
World Neurosurg. 2019 May;125:e205-e213
pubmed: 30684722
Psychol Rev. 2001 Jan;108(1):204-56
pubmed: 11212628
J Neurooncol. 2016 Jun;128(2):195-205
pubmed: 27048208
J Neurosurg. 2012 Dec;117(6):999-1006
pubmed: 23061394
World Neurosurg. 2017 Feb;98:203-210
pubmed: 27989970
Br J Neurosurg. 2001 Apr;15(2):184-8
pubmed: 11360390
J Neurooncol. 2018 May;137(3):611-619
pubmed: 29330748
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Lancet. 2004 May 8;363(9420):1535-43
pubmed: 15135603
Cereb Cortex. 2016 Jul;26(7):3285-96
pubmed: 27102654
Neurosurgery. 2009 Jan;64(1):40-7; discussion 47
pubmed: 19145155
Cancer. 2018 Jan 1;124(1):161-166
pubmed: 28902404
J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):910-5
pubmed: 18653549
J Rehabil Med. 2014 May;46(5):430-7
pubmed: 24763925
Neuro Oncol. 2019 Jul 11;21(7):911-922
pubmed: 30753679
J Neurosurg. 2016 Jun;124(6):1578-84
pubmed: 26636380
Acta Neurochir (Wien). 2019 Mar;161(3):579-588
pubmed: 30756243
Nat Neurosci. 2015 Nov;18(11):1664-71
pubmed: 26457551
Appl Neuropsychol Adult. 2019 Nov-Dec;26(6):503-512
pubmed: 29617166
Nat Neurosci. 2016 Jan;19(1):7-9
pubmed: 26713742
Acta Neurol Scand. 2013 Sep;128(3):185-93
pubmed: 23432636
Arch Clin Neuropsychol. 2006 Oct;21(7):623-43
pubmed: 17014981
J Neurosurg. 2017 Dec;127(6):1242-1248
pubmed: 28186454
Psychooncology. 2019 Aug;28(8):1654-1662
pubmed: 31141624
Clin Neurol Neurosurg. 2016 Apr;143:150-8
pubmed: 26945768
J Neurooncol. 2015 Feb;121(3):617-25
pubmed: 25502961